Skip to content
Home/GPs/dievini Hopp BioTech holding
dievini Hopp BioTech holding

dievini Hopp BioTech holding

Walldorf, Germany·Founded 2005··dievini.de

dievini Hopp BioTech holding is the evergreen life-sciences family-office holding of SAP co-founder Dietmar Hopp and his family, based in Walldorf, Germany. Formalized in 2005 and led today by managing director Dr. Mathias Hothum (with founders Friedrich von Bohlen und Halbach and Christof Hettich), it invests patient balance-sheet capital directly into biotech, therapeutics and diagnostics companies focused on oncology, neurology, infectiology, cell therapy and pharmaceutical formulations, primarily in Germany and Europe. Notable holdings include CureVac, Immatics, AC Immune, Apogenix, Heidelberg Pharma and Molecular Health, with more than EUR 1.3 billion deployed across its portfolio.

AUM
€1.4B
Funds
1
vintages 2005
Portfolio
5
Exits
1
SectorsHealthcare

Key facts

HQWalldorf, Germany
Founded2005
Websitedievini.de

Recent exits

CureVac
Biotech · 2025 · 20yr hold

Coverage notes

1 fund tracked, 6 portfolio companies (5 active · 1 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund dievini Hopp BioTech holding has raised, with its portfolio companies. Hand-checked from public filings.

1 fund
dievini Hopp BioTech holding (Evergreen Balance Sheet)Evergreen
2005 · 21yr€1.4B5 active · 1 realized

Unrealized

5 held
ApogenixActive
BiotechGermany· Entry 2005
BiotechGermany· Entry 2009
ImmaticsActive
BiotechGermany· Entry 2006
SaaSGermany· Entry 2004
NovaliqActive
PharmaGermany· Entry 2007

Realized

1 exit
CureVacExited 2025
BiotechGermany· Entry 2005
Trade Saleto
Track dievini Hopp BioTech holding

Saved GPs appear in your watchlist, one click from your workspace.

Last updated July 2026 · Sourced from public filings